NASH FibroSure

Alphabetical Test listing

NASH FibroSure-994

  
NASH FibroSure
  
994
  
LAB994
  
MSO
  
Fatty liver disease
Nonalcoholic fatty liver disease
Noninvasive liver biopsy
Steatohepatitis
  

This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Quantitative results of 10 biochemicals in combination with age, gender, height, and weight are analyzed using a computational algorithm to provide a quantitative surrogate marker (0.0-1.0) of liver fibrosis (Metavir F0-F4), hepatic steatosis (0.0-1.0, S0-S3), and nonalcoholic steatohepatitis (NASH) (0.0-0.75, N0-N2). The absence of steatosis (S<0.38) precludes the diagnosis of NASH.

  

Patient should be fasting for at least eight hours prior to sample collection.

Fasting for a blood test

 

  
Serum
  
  
3.5 mL
  
2.0 mL
  

Immediatley following collection, mix sample by inverting 5 times

  
  1. Allow sample to clot fpr a minimum of 30 minutes
  2. Spin
  3. Transfer serum to a Screw cap transfer vial/tube (Mayo T465), labelled as serum, within two (2) hours of sample collection
  4. Freeze
  
  
  
  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Screw cap transfer vial/tube (Mayo T465), labelled as serum, within two (2) hours of sample collection
  4. Freeze
  
  • Patient's age
  • Patient's gender
  • Patient height
  • Patient weight
  

Frozen (preferred) - 7 days

Refrigerated - 72 hours

  
  • Gross hemolysis
  • Gross lipemia
  • Improper labeling
  • Nonfasting specimen
  • Patient <14 years of age
  
LabCorp Burlington (550140): R-NX
  
Mo - Fr
  
3 - 6 days
  

An interpretive report will be provided

  
82172
82247
82465
82947
82977
83010
83883
84450
84460
84478
  
Yes
  
  
Result 2345-7
  
11/11/2016
  
05/24/2019